NMC Health Plc reported unaudited consolidated earnings results for the six months ended June 30, 2018. For the period, the company reported revenue of USD 931,970,000 compared to USD 775,153,000 a year ago. Profit from operations before depreciation, amortisation, transaction costs and impairment was USD 225,546,000 compared to USD 170,651,000 a year ago. Profit from operations was USD 179,780,000 compared to USD 130,890,000 a year ago. Profit for the period before tax was USD 118,718,000 compared to USD 99,306,000 a year ago. Profit for the period attributable to equity holders of the parent was USD 116,494,000 or USD 0.557 per diluted share compared to USD 87,729,000 or USD 0.426 per diluted share a year ago. Net cash from operating activities was USD 79,572,000 compared to USD 94,857,000 a year ago. Purchase of property and equipment was USD 55,725,000 compared to USD 22,914,000 a year ago. Purchase of intangible assets was USD 690,000 compared to USD 463,000 a year ago. EBITDA was USD 225.5 million compared to USD 170.7 million a year ago. Adjusted profit was USD 141.4 million or USD 0.669 per share compared to USD 115.8 million or USD 0.514 per share a year ago. Net debt (excluding liability portion of convertible bond) increased to USD 1,152.5 million.

Given the positive developments, management is in process of reviewing its earlier guidance for 2018 (22% year on year revenue growth and EBITDA around USD 465 million), with an update expected to be provided at the 2018 capital markets day.